Hylenex Recombinant Injection, Solution
Product Images NDC 18657-117

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Hylenex Recombinant (NDC 18657-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Antares Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (4 x 1 mL Single Dose Vials Carton)

This is a description of the medication "Hylenex". It is a recombinant human hyaluronidase injection with 150 USP units of the active ingredient in each mL. It comes in single-dose vials and should be stored in the refrigerator between 2°C and 8°C (36°F to 46°F) but should not be frozen. It also contains sodium chloride, dibasic sodium phosphate, albumin human, L-methionine, polysorbate 80, and hydrochloric acid and sodium hydroxide for pH adjustment. The dosage information is available in the enclosed dosing information. It is not recommended for IV use. The manufacturer of this medication is Halozyme Therapeutics Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.